  Poly-L-lactide (PLLA) is a popular choice for medical devices due to its
bioresorbability and superior mechanical properties compared with other
polymers. However, although PLLA has been investigated for use in bioresorbable
cardiovascular stents, it presents application-specific limitations which
hamper device therapies. These include low toughness and strength compared with
metals used for this purpose, and slow degradation. Blending PLLA with novel
polyethylene glycol functionalised
poly(L-lactide-co-$\varepsilon$-caprolactone) (PLCL-PEG) materials has been
investigated here to tailor the mechanical properties and degradation behaviour
of PLLA. This exciting approach provides a foundation for a next generation of
bioresorbable materials whose properties can be rapidly tuned. The degradation
of PLLA was significantly accelerated by addition of PLCL-PEG. After 30 days of
degradation, several structural changes were observed in the polymer blends,
which were dependent on the level of PLCL-PEG addition. Blends with low
PLCL-PEG content displayed enthalpy relaxation, resulting in embrittlement,
while blends with high PLCL-PEG content displayed crystallisation, due to
enhanced chain mobility brought on by chain scission, also causing
embrittlement. Moderate PLCL-PEG additions (10% PLCL(70:30)-PEG and 20 - 30%
PLCL(80:20)-PEG) stabilised the structure, reducing the extent of enthalpy
relaxation and crystallisation and thus retaining ductility. Compositional
optimisation identified a sweet spot for this blend strategy, whereby the
ductility was enhanced while maintaining strength. Our results indicate that
blending PLLA with PLCL-PEG provides an effective method of tuning the
degradation timescale and mechanical properties of PLLA, and provides important
new insight into the mechanisms of structural relaxations that occur during
degradation, and strategies for regulating these.
